Abstract
Of six patients with rheumatoid arthritis (RA) treated with human recombinant interferon gamma for two to eight months, three developed antinuclear antibodies (ANAs). This was accompanied by a simultaneous clinical exacerbation of the disease activity. In this study both anti-inflammatory and immunostimulatory effects of human recombinant interferon gamma in patients with RA were observed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bottazzo G. F., Pujol-Borrell R., Hanafusa T., Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 1983 Nov 12;2(8359):1115–1119. doi: 10.1016/s0140-6736(83)90629-3. [DOI] [PubMed] [Google Scholar]
- Seitz M., Manz G., Franke M. Einsatz von rekombinantem Human-Interferon gamma bei Patienten mit rheumatoider Arthritis. Z Rheumatol. 1986 May-Jun;45(3):93–99. [PubMed] [Google Scholar]